Axena Health is dedicated to improving the lives of women with pelvic floor disorders. Axena Health's flagship product, the Leva® Pelvic Health System, offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions affecting over 78 million and 12 million women in the U.S. alone. Axena Health's technology enables non-invasive, drug-free treatment via precise visualization of movement in real time during pelvic floor muscle training, while monitoring usage and progress.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/04/24 | $9,400,000 | Series A |
Avestria Ventures AXA IM Alts Cross-Border Impact Ventures  KOFA Healthcare | undisclosed |
